, Johnson & Johnson to acquire Momenta Pharma for $6.5 billion
This deal gives J&J access to a new class of drugs that treat autoimmune diseases.
, Johnson & Johnson Loses Baby Powder And Ovarian Cancer Case
Johnson & Johnson (J&J) faced a historically expensive compensation charge on Thursday, July 12, 2018. A Missouri Jury ordered the American baby product giant …
, Alex Gorsky to be Johnson & Johnson’s new CEO After Weldon
Johnson & Johnson has picked up a new CEO, to succeed Bill Weldon after his retirement in April this year. The healthcare giant J&J said its decade-old Chief Executive Officer William Weldon will step down from his post in April. To succeed him is the vice chairman Alex Gorsky, as the ninth chief executive officer of the 126 year-old company, while Weldon, aged 63, remains the chairman of the board.
